CHARLES SCHWAB INVESTMENT MANAGEMENT INC - TALARIS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,517
-7.6%
13,7070.0%0.00%
Q2 2023$41,669
-56.1%
13,707
-72.9%
0.00%
Q1 2023$94,919
+84.3%
50,4890.0%0.00%
Q4 2022$51,499
-64.0%
50,489
-6.6%
0.00%
Q3 2022$143,000
-41.4%
54,0280.0%0.00%
Q2 2022$244,000
-52.4%
54,028
+3.8%
0.00%
Q1 2022$513,000
-32.6%
52,058
+4.7%
0.00%
Q4 2021$761,000
+150.3%
49,706
+121.8%
0.00%
Q3 2021$304,000
-7.9%
22,4100.0%0.00%
Q2 2021$330,00022,4100.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$8,240,62310.94%
BML Capital Management, LLC 2,000,000$5,620,0005.16%
Nantahala Capital Management 2,953,129$8,298,2920.71%
GREAT POINT PARTNERS LLC 1,000,000$2,810,0000.51%
Acuitas Investments, LLC 194,547$546,6770.32%
Affinity Asset Advisors, LLC 400,000$1,124,0000.32%
RA Capital Management 2,403,238$6,753,0990.13%
Artal Group S.A. 914,262$2,5690.11%
Blackstone Inc. 8,089,315$22,730,9750.10%
QVT Financial LP 589,314$1,655,9720.09%
View complete list of TALARIS THERAPEUTICS INC shareholders